AAAAAA

   
Results: 1-12 |
Results: 12
ATTENUATION OF ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA WITH CLOZAPINE
Authors: BUNKER MT MARKEN PA SCHNEIDERHAN ME RUEHTER VL
Citation: Mt. Bunker et al., ATTENUATION OF ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA WITH CLOZAPINE, Journal of child and adolescent psychopharmacology, 7(1), 1997, pp. 65-69
CLOZAPINE USE IN 2 FULL-TERM PREGNANCIES
Authors: STONER SC SOMMI RW MARKEN PA ANYA I VAUGHN J
Citation: Sc. Stoner et al., CLOZAPINE USE IN 2 FULL-TERM PREGNANCIES, The Journal of clinical psychiatry, 58(8), 1997, pp. 364-365
ANTIDEPRESSANT OVERDOSES AND RESULTANT EMERGENCY DEPARTMENT SERVICES - THE IMPACT OF SSRIS
Authors: STONER SC MARKEN PA WATSON WA SWITZER JL BARBER MF MEYER VL SOMMI RW STEELE MT
Citation: Sc. Stoner et al., ANTIDEPRESSANT OVERDOSES AND RESULTANT EMERGENCY DEPARTMENT SERVICES - THE IMPACT OF SSRIS, Psychopharmacology bulletin, 33(4), 1997, pp. 667-670
ANTIDEPRESSANT OVERDOSES AND RESULTANT EMERGENCY DEPARTMENT SERVICES - THE IMPACT OF SSRIS
Authors: STONER SC MARKEN PA WATSON WA SWITZER JL BARBER MF MEYER VL
Citation: Sc. Stoner et al., ANTIDEPRESSANT OVERDOSES AND RESULTANT EMERGENCY DEPARTMENT SERVICES - THE IMPACT OF SSRIS, Psychopharmacology bulletin, 33(3), 1997, pp. 588-588
ANTICHOLINERGIC DRUG-ABUSE AND MISUSE - EPIDEMIOLOGY AND THERAPEUTIC IMPLICATIONS
Authors: MARKEN PA STONER SC BUNKER MT
Citation: Pa. Marken et al., ANTICHOLINERGIC DRUG-ABUSE AND MISUSE - EPIDEMIOLOGY AND THERAPEUTIC IMPLICATIONS, CNS DRUGS, 5(3), 1996, pp. 190-199
SUGGESTIONS TO IMPROVE CONVERSION OF FLUPHENAZINE DOSAGE FORMS
Authors: RALEIGH F MARKEN PA
Citation: F. Raleigh et Pa. Marken, SUGGESTIONS TO IMPROVE CONVERSION OF FLUPHENAZINE DOSAGE FORMS, American journal of health-system pharmacy, 53(14), 1996, pp. 1732-1732
CONVERSION FROM ORAL TO IM FLUPHENAZINE NOT A SIMPLE MATTER
Authors: SCHNEIDERHAN ME GROSS AG MARKEN PA RUEHTER VL SCHMIDT SL
Citation: Me. Schneiderhan et al., CONVERSION FROM ORAL TO IM FLUPHENAZINE NOT A SIMPLE MATTER, American journal of health-system pharmacy, 52(24), 1995, pp. 2826-2827
PRELIMINARY COMPARISON OF PREDICTIVE AND EMPIRIC LITHIUM DOSING - IMPACT ON PATIENT OUTCOME
Authors: MARKEN PA MCCRARY KE LACOMBE S SOMMI RW HORNSTRA RK PIERCE CA STANISLAV SW EVANS RL
Citation: Pa. Marken et al., PRELIMINARY COMPARISON OF PREDICTIVE AND EMPIRIC LITHIUM DOSING - IMPACT ON PATIENT OUTCOME, The Annals of pharmacotherapy, 28(10), 1994, pp. 1148-1152
AN ATYPICAL COURSE OF NEUROLEPTIC MALIGNANT SYNDROME
Authors: SCHNEIDERHAN ME MARKEN PA
Citation: Me. Schneiderhan et Pa. Marken, AN ATYPICAL COURSE OF NEUROLEPTIC MALIGNANT SYNDROME, Journal of clinical pharmacology, 34(4), 1994, pp. 325-334
REVISITING THERAPEUTICS - INNOVATIONS, RESTRUCTURING, AND ASSESSMENT
Authors: SOMMI RW MARKEN PA
Citation: Rw. Sommi et Pa. Marken, REVISITING THERAPEUTICS - INNOVATIONS, RESTRUCTURING, AND ASSESSMENT, American journal of pharmaceutical education, 58(3), 1994, pp. 319-323
CRITERIA FOR USE OF LITHIUM IN ADULT INPATIENTS AND OUTPATIENTS
Authors: MARKEN PA EZELL JR
Citation: Pa. Marken et Jr. Ezell, CRITERIA FOR USE OF LITHIUM IN ADULT INPATIENTS AND OUTPATIENTS, Clinical pharmacy, 12(8), 1993, pp. 617-621
SURVEY OF PSYCHOPHARMACY CURRICULA AND FACULTY AT SCHOOLS OF PHARMACY
Authors: MARKEN PA EVANS RL
Citation: Pa. Marken et Rl. Evans, SURVEY OF PSYCHOPHARMACY CURRICULA AND FACULTY AT SCHOOLS OF PHARMACY, American journal of pharmaceutical education, 57(4), 1993, pp. 330-332
Risultati: 1-12 |